DEGS1 and myeloid leukemia: To circumvent this problem, we generated DEGS1 KO cells via the CRISPR/Cas9 system using myelogenous leukemia-derived human HAP1 cells, which are near-haploid and therefore facilitate the easy generation of KO cells.